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Introduction
Hypertension is associated with alterations in the endothelial 
function of arterial resistance and is often accompanied by severe 
complications, e.g., stroke, ischemic heart disease and nephroscler-
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Background and Objectives: Circulating endothelial progenitor cells (EPCs) play a key role in the maintenance of endothelial homeosta-
sis and promote vascular repair. A reduced number of EPCs and the functional activity have been associated with several cardiovascular risk 
factors. However, the relationship between the number of EPCs and circadian rhythm of the blood pressure (BP) remains unclear. The purpose 
of the present study was to evaluate the relationship between the circadian rhythm of the BP and EPCs in patients with essential hypertension.
Subjects and Methods: A total of 45 patients with essential hypertension who were newly identified by outpatient BP measurements, 
underwent 24-hour ambulatory BP monitoring. Among the 45 patients with essential hypertension, 20 were classified as dippers (12 men 
and 8 women; mean age 48±14 years) and 25 as non-dippers (14 men and 11 women; mean age 52±18 years). The EPC count was isolated 
from the peripheral bloodstream and quantified by flow cytometry.
Results: The baseline clinical characteristics were similar between the dipper and non-dipper hypertensive patients. The circulating EPCs 
were statistically reduced in the non-dipper patients as compared to the dippers (104±60 vs. 66±47 EPCs per 106 mononuclear cells, 
p=0.027). The circulating EPC level correlated positively with the circadian changes in the systolic and diastolic BP (r=0.435, p=0.003, and 
r=0.310, p=0.038, respectively). 
Conclusion: The present study demonstrated that the EPC count was reduced in the peripheral bloodstream in non-dipper hypertensive 
patients. (Korean Circ J 2012;42:329-334)
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osis, which are associated with vascular damage. The dysfunctional 
endothelium and resulting structural changes may be responsible 
for the adverse outcomes of hypertension.
1)
Blood pressure (BP) tends to be higher in the early morning hours 
than at other times of the day, and the nighttime BP is generally 10-
20% lower than the daytime BP. A non-dipper rhythm refers to a 
circadian change in BP in which a nocturnal decrease in the BP is 
attenuated or absent. Patients with a non-dipper circadian rhythm 
of the BP have a greater risk of cerebrovascular and cardiovascular 
complications than those with a dipper circadian rhythm.
2)
Endothelial progenitor cells (EPCs) derived from the bone mar-
row circulate in the peripheral bloodstream and have been impli-
cated in neoangiogenesis after tissue ischemia has occurred, and 
are candidates for vascular regeneration.
3) Thus, circulating EPCs 
play a key role in the maintenance of endothelial homeostasis and 
promote vascular repair. They may also have a predictive value for 
cardiovascular events. A reduced EPC count and associated func-330  EPC in Non-Dipper Hypertensive Patients
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tional activity have been associated with several cardiovascular risk 
factors, but their relationship to non-dipper hypertension remains 
unclear.
4-6)
Therefore, we conducted the present study to investigate whether 
the circulating EPC level was altered in patients with non-dipper hy-
pertension who were at high risk for cardiovascular disease and to 
evaluate the relationship between the circadian rhythm of the BP 
and circulating EPC level in patients with essential hypertension. 
Subjects and Methods
Subjects
Between December 2007 and May 2008, 47 patients with essen-
tial hypertension who were recently identified by outpatient BP mea-
surements and had not previously received antihypertensive ther-
apy were included in this study. After 5 minutes of rest in the sitting 
position, BP was measured by a calibrated mercury sphygmomano-
meter, and defined as the average of at least 2 measurements re-
corded 3 minutes apart. Two patients were excluded because of 
their refusal, and blood samples were obtained from the remaining 
45 patients. Patients with recent cardiovascular events, concomi-
tant malignant diseases or active inflammation were excluded 
from this study. All individuals were on an unrestricted diet and gave 
their informed consent according to the protocol approved by the 
Ethical Committee of our Hospital.
Ambulatory blood pressure monitoring
All patients underwent 24-hour ambulatory BP monitoring (TO-
NOPORT V, GE Marquette, Milwaukee, WI, USA). The patients were 
divided into two groups, dippers and non-dippers, according to their 
nocturnal decrease in BP. Patients whose nocturnal decrease in sys-
tolic BP was ≥10% of the daytime systolic BP were classified as dip-
pers, and those whose nocturnal decrease in systolic BP was <10% 
of the daytime systolic BP were classified as non-dippers.
7) 
 
Isolation of circulating endothelial progenitor cells 
In all participants, the total EPC count was assessed by using an 
in vitro assay, as described previously.
8) In brief, mononuclear cells 
(MNCs) were obtained from peripheral blood samples (100 μL), and 
the EPCs were identified by flow cytometry (BD Biosciences, San 
Jose, CA, USA). Their phenotype was determined by immunohisto-
chemistry after staining with 20 μL fluorescein PE-Cy5-conjugated 
anti-CD45 monoclonal antibody (Dynona, Korea), 20 μL of fluores-
cein isothiocyanate (FITC)-conjugated anti-CD34 monoclonal anti-
body (Dynona, Korea) and 10 μL of PE-conjugated anti-vascular 
endothelial growth factor receptor 2 (VEGFR2) monoclonal antibody 
(R&D, Minneapolis, MN, USA), and further incubated in a dark room 
for 1 hour. After appropriate gating with low cytoplasmic granularity 
and a low expression of CD45, the number of CD34
+VEGFR2
+ cells 
was quantified and expressed as the absolute number of cells per 
1×10
6 peripheral MNCs. The total number of CD45
lowCD34
+ VEG-
FR2
+ cells was then counted (Fig. 1).
Statistical analysis
All statistical analysis was performed using the Statistical Pack-
age for the Social Sciences (SPSS Inc., Chicago, IL, USA) for Win-
dows 12.0. All data are expressed as means±standard deviations. 
The Student’s t-test was used for comparisons of the measured 
values between the dipper and non-dipper hypertensive patients. 
A Pearson’s correlation coefficient between the number of EPSs and 
circadian changes in the BP were calculated. A p<0.05 was consider-
ed statistically significant.
Fig. 1. Quantification of EPCs by flow cytometry. Circulating EPCs were identified by flow cytometry with low cytoplasmic granularity (R1) and with ex-
pression of cell surface antigens such as CD45
lowCD34
+ VEGFR2
+. Arrows indicate CD45
lowCD34
+ VEGFR2
+ cells. EPCs: endothelial progenitor cells, VEGFR2: 
vascular endothelial growth factor receptor 2, SSC: side scather, FITC: fluorescein isothiocyanate.
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Results
Subject characteristics
Among the 45 patients with essential hypertension, 20 were clas-
sified as dippers (12 men and 8 women; mean age 48±14 years) and 
25 as non-dippers (14 men and 11 women; mean age 52±18 years). 
The baseline characteristics of the dipper and non-dipper hyper-
tensive patients are shown in Table 1. The clinical characteristics and 
laboratory parameters were similar between the dipper and non-
dippers except for the number of lymphocytes (2.5±0.6 vs. 2.1± 
0.7×10
3/uL; p=0.02) and left ventricular ejection fraction (70.8±6.0% 
vs. 64.8±11.1%; p=0.04). 
Comparison of differences in the endothelial progenitor cell 
count between the dippers and non-dippers 
The difference in the circulating number of EPCs between the 
dippers and non-dippers is presented in Fig. 2. The absolute num-
ber of circulating EPCs was significantly reduced in the non-dipper 
hypertensive patients as compared to the dippers (104±60 vs. 
66±47 EPCs per 10
6 MNCs, p=0.027) (Fig. 2). 
Relationship between the endothelial progenitor cell count 
and parameters
The correlation between the EPC count and parameters is shown 
in Table 2. The EPC count correlated positively with the number of 
lymphocytes and the glucose level (r=0.625, p<0.001, and r=0.318, 
p=0.035, respectively). 
Relationship between the endothelial progenitor cell count 
and circadian changes in the blood pressure
The correlation between the EPC count and the circadian changes 
in the BP is presented in Fig. 3. The number of circulating EPCs cor-
related positively with the circadian changes in the systolic blood 
pressure and diastolic blood pressure (r=0.435, p=0.003, and r= 
0.310, p=0.038, respectively) (Fig. 3).
Table 1. Baseline characteristics of the patients evaluated in this study
Dipper
(n=20)
Non-dipper
(n=25)
p
Age (year) 48±14 52±18 0.35
Sex (M : F) 12 : 8 14 : 11
Office blood pressure (mm Hg)
    Systolic 143±12 140±16 0.45
    Diastolic 99±11 93±11 0.11
24-hour ambulatory BP monitor  
  (mm Hg)
    Day-time average SBP 146.8±13.8 140.2±16.1 0.32
    Day-time average DBP 101.6±12.2 93.6±10.4 0.62
    Night-time average SBP 127.8±10.4 137.0±17.6 0.19
    Night-time average DBP 85.0±9.4 90.3±11.6 0.38
Heart rate (beats/minute) 74±8 74±10 0.98
Smoking status, n (%)
    Current 3 (15) 2 (8) 0.46
    Former 11 (55) 19 (76) 0.14
    Never 6 (30) 4 (16) 0.26
Diabetes mellitus, n (%) 1 (5) 0 0.26
Body mass index (kg/m
2) 27±3 25±5 0.11
Laboratory values
    WBC (×10
3/uL) 7.5±2.6 6.7±1.6 0.22
    Lymphocyte (×10
3/uL) 2.5±0.6 2.1±0.7 0.02
    Glucose (mg/dL) 105.0±24.0 102.0±26.0 0.71
    Creatinine (mg/dL) 0.7±0.2 0.9±0.2 0.74
    Estimated GFR (mL/min/1.73 m
2) 75.2±29.0 67.9±32.3 0.44
    hs-CRP (mg/L) 1.9±2.2 2.2±3.1 0.74
Lipids profiles (mg/dL)
    Total-cholesterol 201.0±37.9 193.0±37.4 0.49
    Triglycerides 188.0±107.0 146.0±101.6 0.19
    HDL-C 47.2±12.1 53.1±13.3 0.14
    LDL-C 114.0±39.4 106.0±28.0 0.43
Echocardiographic measures
    LV ejection fraction (%) 70.8±6.0 64.8±11.1 0.04
Medication, n (%)
    Statin 0 0
Data are expressed as mean±SD or number (%). SBP: systolic blood pres-
sure, DBP: diastolic blood pressure, WBC: white blood cell, GFR: glomerular 
filtration rate, hs-CRP: high sensitivity C-reactive protein, HDL-C: high 
density lipoprotein-cholesterol, LDL-C: low density lipoprotein-cholesterol, 
LV: left ventricular, ACE: angiotensin-converting enzyme, ARB: angiotensin 
receptor blocker, CCB: calcium channel blocker
Fig. 2. Comparison of the difference in the EPC count between the dippers 
and non-dippers. The absolute number of circulating EPCs was significantly 
reduced in the non-dipper hypertensive patients as compared to the dippers 
(104±60 vs. 66±47 EPCs per 10
6 mononuclear cells, p=0.027).  EPC: endo-
thelial progenitor cell, VEGFR2: vascular endothelial growth factor receptor 
2, MNCs: mononuclear cells.
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Discussion
The present study showed that the concentration of the circul-
ating EPCs was significantly reduced in the non-dipper hypertensive 
patients as compared to the dipper hypertensive patients. More-
over, the circulating EPC count correlated positively with the circa-
dian changes in the systolic and diastolic BPs. To the best of our kn-
owledge, this is the first report to show such a relationship between 
the EPCs and circadian changes in the BP.
Experimental and clinical studies have suggested that there is an 
evolving role of the EPCs in neoangiogenesis and rejuvenation of the 
endothelial monolayer.
9)10) Several studies have confirmed that EPCs 
are derived from the bone marrow, circulate in the peripheral blood-
stream and may contribute to new vessel formation by homing in to 
sites such as ischemic tissues and tumor microenvironments in vi-
tro.
11)12) Thus, EPCs would appear to play a key role in the mainte-
nance of endothelial homoeostasis. Recent studies have shown 
that the EPC count and function can predict the occurrence of car-
diovascular events and, most importantly, their imbalance may lead 
to the development of atherosclerosis.
13)
In healthy men, the EPC level may be a surrogate biologic marker 
for vascular function and cumulative cardiovascular risk. These find-
ings suggest that endothelial injury in the absence of sufficient cir-
culating EPCs may affect the progression of cardiovascular disease.
6)
Regarding the relationship between EPCs and cardiovascular 
events, Schmidt-Lucke et al.
14) demonstrated that patients with car-
diovascular events have fewer circulating EPCs and that a low num-
ber of EPCs independently predicts a higher occurrence of cardio-
vascular events. Similar results were obtained by Werner et al.
5) who 
found coronary artery disease (CAD) a significant inverse relation-
ship in patients with CAD between the EPC levels and rate of car-
diovascular death, revascularization and hospitalization.
Hypertension is one of the most well-known cardiovascular risk 
factors for target organ damage and cardiovascular events. There is 
no doubt that the effect of hypertension on the vascular wall is one 
of the most important determinants of this enhanced risk. With re-
gard to hypertension, it has been shown that patients with CAD have 
a reduced level and migratory capacity of EPCs, and the latter is 
mainly influenced by hypertension.
Imanishi et al.
15) reported that EPC senescence is accelerated in 
essential hypertensive patients and positively correlates with the se-
verity of hypertension. Oliveras et al.
16) demonstrated that the EPC 
concentration in the peripheral bloodstream and after in vitro cul-
Table 2. Correlation between EPC count and the different parameters
Parameters R p
Age (year) 0.005 0.975
Blood pressure (mm Hg)
    Systolic 0.068 0.655
    Diastolic -0.009 0.952
Heart rate (beats/minute) -0.105 0.494
Smoking status, n (%) -0.105 0.491
Body mass index (kg/m
2) 0.098 0.523
Laboratory values
    WBC (×10
3/uL) 0.136 0.371
    Lymphocyte (×10
3/uL) 0.625 <0.001
    Glucose (mg/dL) 0.318 0.035
    Creatinine (mg/dL) -0.001 0.996
    Estimated GFR (mL/min/1.73 m
2) -0.096 0.537
    hs-CRP (mg/L) 0.049 0.760
Lipid profiles (mg/dL)
    Total cholesterol 0.227 0.139
    Triglycerides 0.094 0.544
    HDL-C 0.082 0.598
    LDL-C 0.154 0.317
Echocardiographic measures
    LV ejection fraction (%) 0.087 0.581
EPC: endothelial progenitor cell, WBC: white blood cell, GFR: glomerular fil-
tration rate, hs-CRP: high sensitivity C-reactive protein, HDL-C: high density 
lipoprotein-cholesterol, LDL-C: low density lipoprotein-cholesterol, LV: left 
ventricular
Fig. 3. Relationship between the EPC count and circadian changes in the BP. A: the number of circulating EPCs correlated positively with the circadian 
changes in the systolic blood pressure (r=0.435, p=0.003). B: the number of circulating EPCs also correlated positively with circadian changes in the dia-
stolic blood pressure (r=0.310, p=0.038).
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tures was reduced in patients with refractory hypertension. This 
decrease was independent of the other risk factors and known de-
terminants of EPCs. This reinforced a likely role of EPCs in athero-
sclerosis development.
It has been reported that the average lifespan of EPCs is short-
ened by oxidative stress and regulated by anti-oxidative mecha-
nisms. Angiotensin II receptor antagonists improve EPC dysfunc-
tion and increase cardiac c-kit expression through an anti-oxidative 
mechanism during hypertension. The local renin-angiotensin system 
induces oxidative stress and regulates EPC function.
17-19) In addition, 
we previously reported that the number of circulating EPCs and 
flow-mediated vasodilatation (FMD) reduced in vasospastic angina, 
and statin treatment increased EPC count and FMD.
20)
In the present study we showed that the concentration of circul-
ating EPCs is significantly reduced in non-dipper hypertensive pa-
tients as compared to dipper hypertensive patients. The reduction 
in non-dippers may account for the known high cardiovascular risk 
in these patients. It would be interesting to know the pharmacolo-
gical and non-pharmacological measures that upregulate EPCs in 
the early stages of potentially high cardiovascular risk patients to 
prevent them from developing atherosclerosis and minimize the risk 
of adverse outcomes. 
Our study had several limitations. First, the sample size was small. 
Second, we could not perform a functional study of the EPCs. Thus, 
we could not learn the correlation between the EPC functional pro-
perties and hypertensive patients. Finally, the specific phenotype of 
EPCs has not yet been elucidated and there is no defined universal 
agreement on the characterization of EPCs. Thus, the surface cell 
markers that we used in our study were not sufficiently precise. 
However, even considering that all these cells were not true EPCs, 
they possessed a proven angiogenic potential and may therefore be 
considered endothelial progenitors in a wide sense.
In conclusion, the present study demonstrated that EPC concentr-
ation in the peripheral bloodstream reduced in non-dipper hyper-
tensive patients and circulating EPCs statistically correlated posi-
tively with the circadian changes in the BP. However, the clinical sig-
nificance of the reduced circulating EPCs in non-dippers was unclear. 
Therefore, these findings need to be confirmed in follow-up studies. 
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